<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="skip">
            <roleset id="Skip.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#x09;&#x09;&#x09;// mutation, cell, molecule//&#x0A;" />
                    <role n="1" descr="entity skipped           &#x09;// exon, intron, process  //&#x0A;" />
                    <role n="R" descr="results/consequences&#x0A;" />
                </roles>
              
                <example src="EGRAM" no="*0">
                    <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which has skipped exon 3, an event that leads to peroxisome deficiency.</text>
                    <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                    <arg n="1">exon 3</arg>
                </example>
              <example src="EGRAM" no="*0">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) skipping exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*0">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) having skipped exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
                <example src="EGRAM" no="*1">
                    <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which skips exon 3, an event that leads to peroxisome deficiency.</text>
                    <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                    <arg n="1">exon 3</arg>
                </example>
              <example src="EGRAM" no="*1">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which usually skips exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
                <example src="EGRAM" no="*2">
                    <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which will skip exon 3, an event that leads to peroxisome deficiency.</text>
                    <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                    <arg n="1">exon 3</arg>
                </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which may skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which can skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which may have skipped exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which is able to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) being able to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which is observed to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) being observed to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) observed to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which has been shown to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) having been shown to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) shown to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A), which is likely to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              <example src="EGRAM" no="*2">
                <text>Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G--&gt;A) being likely to skip exon 3, an event that leads to peroxisome deficiency.</text>
                <arg n="0">a splice-site mutation in intron 3 (IVS3+1G--&gt;A)</arg>
                <arg n="1">exon 3</arg>
              </example>
              
                <example src="EGRAM" no="*3">
                    <text>Finally, a stop codon-containing exon (exon 4) could be skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein.</text>
                    <arg n="0">alternative splicing</arg>
                    <arg n="1">a stop codon-containing exon (exon 4)</arg>
                </example>
                <example src="EGRAM" no="*4">
                    <text>Finally, a stop codon-containing exon (exon 4) has been skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein.</text>
                    <arg n="0">alternative splicing</arg>
                    <arg n="1">a stop codon-containing exon (exon 4)</arg>
                </example>
                <example src="EGRAM" no="*5">
                    <text>Finally, a stop codon-containing exon (exon 4) is skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein.</text>
                    <arg n="0">alternative splicing</arg>
                    <arg n="1">a stop codon-containing exon (exon 4)</arg>
                </example>
                <example src="EGRAM" no="*6">
                    <text>Finally, a stop codon-containing exon (exon 4) was skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein.</text>
                    <arg n="0">alternative splicing</arg>
                    <arg n="1">a stop codon-containing exon (exon 4)</arg>
                </example>
                <example src="EGRAM" no="*7">
                    <text>Finally, a stop codon-containing exon (exon 4) will be skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                    <arg n="0">alternative splicing</arg>
                    <arg n="1">a stop codon-containing exon (exon 4)</arg>
                </example>
              <example src="EGRAM" no="*7">
                <text>Finally, a stop codon-containing exon (exon 4) may have been skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, a stop codon-containing exon (exon 4) is believed to be skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, a stop codon-containing exon (exon 4) is able to be skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, a stop codon-containing exon (exon 4) has been shown to be skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, a stop codon-containing exon (exon 4) has the probability of being skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, a stop codon-containing exon (exon 4) has the ability to be skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>

              <example src="EGRAM" no="*3">
                <text>A stop codon-containing exon (exon 4) could be finally skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*4">
                <text>A stop codon-containing exon (exon 4) has been finally skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*5">
                <text>A stop codon-containing exon (exon 4) is finally skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*6">
                <text>A stop codon-containing exon (exon 4) was finally skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) will be finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) may have been finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) is believed to be finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) is able to be finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) has been shown to be finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) has the probability of being finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>A stop codon-containing exon (exon 4) has the ability to be finally skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>

              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing skips a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing has skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing can skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing may have skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing is able to skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing has been shown to skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing has the ability to skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Finally, alternative splicing is likely to skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>

              <example src="EGRAM" no="*7">
                <text>Alternative splicing finally skips a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing finally skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing has finally skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing can finally skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing may have finally skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing is able to finally skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing has been shown to finally skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing has the ability to finally skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing is likely to finally skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein.</text>
                <arg n="0">alternative splicing</arg>
                <arg n="1">a stop codon-containing exon (exon 4)</arg>
              </example>

              <example src="EGRAM" no="*8">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII has efficiently skipped the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*9">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII efficiently skipped the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*10">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII efficiently skips the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII will efficiently skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII can efficiently skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII may have efficiently skipped the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII has the ability to efficiently skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII is observed to efficiently skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII has been shown to efficiently skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>

              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step is efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step was efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step has been efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step will be efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step may have been efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step is observed to be efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step is able to be efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step has been shown to be efficiently skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>

              <example src="EGRAM" no="*8">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII has skipped the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*9">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII skipped the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*10">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII skips the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII will skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII can skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII may have skipped the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII has the ability to skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII is observed to skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, an acyl-enzyme intermediate on PikAIII has been shown to skip the last extension step and is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>

              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step is skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step was skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step has been skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step will be skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step may have been skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step is observed to be skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step is able to be skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>In the case of the 12-membered ring macrolide, the last extension step has been shown to be skipped by an acyl-enzyme intermediate on PikAIII which is cyclized by the TE domain of PikAIV, presumably as a result of a PikAIII-PikAIV interaction.</text>
                <arg n="0">an acyl-enzyme intermediate on PikAIII</arg>
                <arg n="1">the last extension step</arg>
              </example>              
              
                <example src="EGRAM" no="12">
                    <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells entered mitosis but have skipped anaphase B and cytokinesis.</text>
                    <arg n="0">the cells</arg>
                    <arg n="1">anaphase B and cytokinesis</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells entered mitosis but skipped anaphase B and cytokinesis.</text>
                    <arg n="0">the cells</arg>
                    <arg n="1">anaphase B and cytokinesis</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but can skip anaphase B and cytokinesis.</text>
                    <arg n="0">the cells</arg>
                    <arg n="1">anaphase B and cytokinesis</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but will skip anaphase B and cytokinesis.</text>
                    <arg n="0">the cells</arg>
                    <arg n="1">anaphase B and cytokinesis</arg>
                </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but may have skipped anaphase B and cytokinesis.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but will be able to skip anaphase B and cytokinesis.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but have the ability to skip anaphase B and cytokinesis.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but are observed to skip anaphase B and cytokinesis.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but have been shown to skip anaphase B and cytokinesis.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which the cells enter mitosis but are likely to skip anaphase B and cytokinesis.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>

              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis are skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis were skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis have been skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis can be skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis may have been skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis are able to be skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis are observed to be skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
              <example src="EGRAM" no="15">
                <text>Megakaryocytes undergo an endomitotic cell cycle, which consists of an S phase interrupted by a gap, during which anaphase B and cytokinesis has been shown to be skipped by the cells.</text>
                <arg n="0">the cells</arg>
                <arg n="1">anaphase B and cytokinesis</arg>
              </example>
                            
                <example src="EGRAM" no="16">
                    <text>The centromere has been skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>The centromere is skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>The centromere may have been skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>The centromere will be skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>The centromere is able to be skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>The centromere is observed to be skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>The centromere has been shown to be skipped on all Tg autosomes as on the female Xi.</text>
                    <arg n="1">The centromere</arg>
                </example>
              <example src="EGRAM" no="22">
                <text>The centromere has the ability to be skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="16">
                <text>The centromere has been finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="17">
                <text>The centromere is finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="18">
                <text>The centromere may have been finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="19">
                <text>The centromere will be finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="20">
                <text>The centromere is able to be finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="21">
                <text>The centromere is observed to be finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="22">
                <text>The centromere has been shown to be finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              <example src="EGRAM" no="22">
                <text>The centromere has the ability to be finally skipped on all Tg autosomes as on the female Xi.</text>
                <arg n="1">The centromere</arg>
              </example>
              
                <example src="EGRAM" no="23">
                    <text>The observation that Tg Xist RNA has skipped the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                    <arg n="0">Tg Xist RNA</arg>
                    <arg n="1">the ectopic Xic</arg>
                    <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>The observation that Tg Xist RNA skipped the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                    <arg n="0">Tg Xist RNA</arg>
                    <arg n="1">the ectopic Xic</arg>
                    <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>The observation that Tg Xist RNA will skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                    <arg n="0">Tg Xist RNA</arg>
                    <arg n="1">the ectopic Xic</arg>
                    <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
                </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA can skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA may have skipped the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA is able to skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA is observed to skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA is likely to skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA has been shown to skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA has the ability to skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA has the probability of skipping the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>

              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic was skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic has been skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic can be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic will be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic may have been skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is able to be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is likely to be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is observed to be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic has been shown to be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic has the ability to be skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="23">
                <text>The observation that Tg Xist RNA has efficiently skipped the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that Tg Xist RNA efficiently skipped the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA will efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA can efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA may have efficiently skipped the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA is able to efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA is observed to efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA is likely to efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA has been shown to efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA has the ability to efficiently skip the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>The observation that Tg Xist RNA has the probability of efficiently skipping the ectopic Xic raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>

              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic was efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic has been efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic can be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic will be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic may have been efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is able to be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is likely to be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic is observed to be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic has been shown to be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>The observation that the ectopic Xic has the ability to be efficiently skipped by Tg Xist RNA raises the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi.</text>
                <arg n="0">Tg Xist RNA</arg>
                <arg n="1">the ectopic Xic</arg>
                <arg n="R">the possibility that the Xic lacks Xist-binding sites and therefore escapes inactivation on the Xi</arg>
              </example>              
                
                <example src="EGRAM" no="*27">
                    <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes translated the most 5'-proximal short ORF (sORF A), then skipped a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                    <arg n="0">ribosomes</arg>
                    <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
                </example>
                <example src="EGRAM" no="*28">
                    <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes have translated the most 5'-proximal short ORF (sORF A), then have skipped a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                    <arg n="0">ribosomes</arg>
                    <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
                </example>
                <example src="EGRAM" no="*29">
                    <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes translate the most 5'-proximal short ORF (sORF A), then will skip a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                    <arg n="0">ribosomes</arg>
                    <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
                </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes translate the most 5'-proximal short ORF (sORF A), then may have skipped a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes translate the most 5'-proximal short ORF (sORF A), then become able to skip a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes translate the most 5'-proximal short ORF (sORF A), then are observed to skip a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which ribosomes translate the most 5'-proximal short ORF (sORF A), then have been shown to skip a large region of the leader containing a putative RNA encapsidation signal and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal is skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal was skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal has been skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal will be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal can be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal may have been skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal is able to be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal is observed to be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal has been shown to be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal is likely to be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Translation of this RNA is initiated by a ribosome shunt mechanism, in which a large region of the leader containing a putative RNA encapsidation signal has the ability to be skipped by ribosomes that translate the most 5'-proximal short ORF (sORF A) and reinitiate translation at the first long viral ORF.</text>
                <arg n="0">ribosomes</arg>
                <arg n="1">a large region of the leader containing a putative RNA encapsidation signal</arg>
              </example>
              
                <example src="EGRAM" no="30">
                    <text>Xist RNA coated the autosome but has skipped the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                    <arg n="0">Xist RNA</arg>
                    <arg n="1">the Xic Tg</arg>
                  <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>Xist RNA coats the autosome but skips the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                  <arg n="0">Xist RNA</arg>
                  <arg n="1">the Xic Tg</arg>
                  <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>Xist RNA coats the autosome but will skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                  <arg n="0">Xist RNA</arg>
                  <arg n="1">the Xic Tg</arg>
                  <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
                </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but can skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but is able to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but is observed to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but has been shown to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but has the ability to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>

              <example src="EGRAM" no="30">
                <text>Xist RNA coated the autosome but, as we predicted, has skipped the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="31">
                <text>Xist RNA coats the autosome but, as we predicted, skips the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but, as we predicted, will skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but, as we predicted, can skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but, as we predicted, is able to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but, as we predicted, is observed to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but, as we predicted, has been shown to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
              <example src="EGRAM" no="32">
                <text>Xist RNA coats the autosome but, as we predicted, has the ability to skip the Xic Tg, raising the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding.</text>
                <arg n="0">Xist RNA</arg>
                <arg n="1">the Xic Tg</arg>
                <arg n="R">the possibility that X chromosome domains escape inactivation by excluding Xist RNA binding</arg>
              </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
